Healthy Clinical Trial
Official title:
Who Fares Best With Mindfulness Meditation - Understanding the Individual Effects of Mindfulness
The overall aim of this observational study is to investigate how individual differences influence the effects of mindfulness meditation to uncover for whom mindfulness is beneficial and for whom it may be harmful. The first objective is to identify the mechanisms underlying the effects of mindfulness meditation on mental health. The second objective is to examine how three candidate factors, namely trauma symptoms, tendency to dissociate, and repetitive negative thinking, influence the effect of mindfulness meditation on mental health. Adults who enrolled for a Mindfulness-Based Intervention (MBI) at the participating sites (n=120 for each site) will be invited to participate. Before the start of the MBI, after half of the sessions, at the end of the MBI and at 3-months follow-up, participants will complete self-report questionnaires. The main outcomes are symptoms of anxiety and depression, quality of life, wellbeing, and adverse effects resulting from the MBI. A subset of participants will be invited for a semi-structured interview after the end of the intervention.
Status | Recruiting |
Enrollment | 360 |
Est. completion date | January 2025 |
Est. primary completion date | January 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Enrolled in a mindfulness-based intervention at one of the participating sites Exclusion Criteria: - Insufficient knowledge of the Dutch or English language (depending on the study site) - No internet access |
Country | Name | City | State |
---|---|---|---|
Belgium | ZNA Stresskliniek | Antwerp | |
Belgium | Mindful Me | Deinze | |
United Kingdom | AccEPT clinic | Exeter |
Lead Sponsor | Collaborator |
---|---|
Prof. dr. Filip Raes | University of Exeter |
Belgium, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Previous experience with meditation | An 8-item scale measuring participants' previous experience with meditation including duration of practice and frequency of practice during the last 4 weeks. | Before the MBI | |
Other | Frequency of mindfulness home practice | A 4-item scale measuring frequency and duration of home practice during the last 4 weeks. | 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI | |
Other | Change in Practice Quality-Mindfulness (PQ-M) | The PQ-M is a 6-item scale that measures quality of mindfulness practice during the last meditation session. Items are scored on a VAS scale ranging from 0% (the statement reflects my experience none of the time) to 100% (the statement reflects my experience all of the time). | 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI | |
Other | Intentions of meditation practice | A 2-item scale measuring intentions for meditation practice on a 7-point Likert scale ranging from "never" to "every time I meditate". | 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI | |
Other | Modified version of the Credibility/ Expectancy Questionnaire (CEQ) | The CEQ is a 4-item scale that measures training expectancy. Items are scored on a 9-point Likert scale ranging from 1 (not at all) to 9 (very much). | Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI | |
Other | Session attendance | A 2-item scale measuring number of attended sessions and drop-out. | 8 weeks after start of MBI | |
Primary | Change in Patient Health Questionnaire-4 (PHQ-4) | The PHQ-4 is a 4-item scale that measures symptoms of depression and anxiety over the last two weeks. Items are scored on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). | Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI | |
Primary | Change in Recovering Quality of Life (ReQol-10) | The ReQol-10 is a 10-item scale that measures quality of life over the last week. Items are scored on a 5-point Likert scale ranging from 0 (none of the time) to 4 (most or all of the time). | Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI | |
Primary | Change in Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) | The SWEMWBS is a 7-item scale that measures wellbeing over the last two weeks. Items are scored on a 5-point Likert scale ranging from 1 (none of the time) to 5 (all of the time). | Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI | |
Primary | Change in Meditation-Related Adverse Effects Scale, Mindfulness-Based Program version (MRAES-MBP) | The MRAES-MBP is a 14-item scale that measures mindfulness-related adverse events over the last four weeks. Items are scored on a 5-point Likert scale ranging from 1 (never) to 5 (very often). | Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI | |
Secondary | Subjective experience of mindfulness practice effects assessed during interview | Subjective experience of the impact of mindfulness practice on participants' lives and what factors contributed to their experience of mindfulness practice. | 8 weeks after start of MBI | |
Secondary | Change in Comprehensive Inventory of Mindfulness Experiences - Short Form (CHIME-SF) | The CHIME-SF is a 24-item scale that measures mindfulness skills over the last two weeks. Items are scored on a 6-point Likert scale ranging from 1 (never or almost never) to 6 (always or almost always). | Before the MBI, 4-weeks after start of MBI, 8 weeks after start of MBI, and 3 months after the end of the MBI | |
Secondary | Brief Dissociative Experiences Scale (DES-B) | The DES-B is a 8-item scale that measures participants' tendency to dissociate. Items are scored on a VAS scale ranging from 0% (never) to 100% (always). | Before the MBI | |
Secondary | Perseverative Thinking Questionnaire (PTQ) | The PTQ is a 15-item scale that measures repetitive negative thinking. Items are scored on a 5-point Likert scale ranging from 0 (never) to 4 (almost always). | Before the MBI | |
Secondary | Modified version of the Life Events Checklist for DSM-5 (LEC-5) | The LEC-5 is a 17-item scale that measures exposure to traumatic events. Items are scored as either yes (happened to you, you witnessed it, you learned about it happening to a close friend or family member, or you were exposed to it as part of your job) or no (event does not apply to you). | Before the MBI | |
Secondary | International Trauma Questionnaire (ITQ) | The ITQ is a 18-item scale that measures PTSD symptoms. Items are scored on a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely). | Before the MBI | |
Secondary | Obsessive Beliefs Questionnaire (OBQ-9) | The OBQ-9 is a 9-item scale that measures obsessive-compulsive disorder related beliefs. Items are scored on a 7-point Likert scale ranging from 1 (disagree very much) to 7 (agree very much). | Before the MBI |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |